Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor alpha-induced interleukin 8 secretion is a signaling pathway activated by TNF-α binding to its receptors, leading to increased IL-8 (CXCL8) production. This process involves activation of NF-kB, MAPK, and PI3K/Akt pathways, resulting in neutrophil recruitment and inflammation. Dysregulation of this pathway is implicated in various chronic inflammatory diseases and cancer.
Inhibition of TNF-α signaling, Inhibition of IL-8/CXCL8 activity, Inhibition of downstream signaling pathways (NF-kB, MAPK, PI3K/Akt)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor alpha-induced interleukin 8 secretion.